Feb 06, 2019 -
Germany will seek a reform of European Union (EU) competition regulations following the decision by the European Competition Directorate to reject Siemens' and Alstom's application to merge their rail businesses.
Jan 23, 2019 - A low key week for the biotech sector with regular drug approvals and pipeline updates.
Dec 18, 2018 - Albireo Pharma (NASDAQ:ALBO) announces the European Commission (EC) has granted orphan designation to A4250, an ileal bile acid transporter inhibitor, for the treatment of biliary atresia, a
Dec 13, 2018 - The European Commission (EC) has approved Novartis' (NYSE:NVS) Xolair (omalizumab) prefilled syringe for self-administration for patients with severe allergic asthma and chronic spontaneous ur
Dec 05, 2018 - The Zacks Analyst Blog Highlights: Royal Dutch, Par Pacific, Precision Drilling, Petrobras and Ecopetrol
Dec 04, 2018 - Royal Dutch Shell (RDS.A) became the first oil company to link executive pay with carbon emissions, while Par Pacific Holdings (PARR) entered into an acquisition to bolster its downstream operations.
Nov 30, 2018 -
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech stocks hitting 52-week highs on Nov. 29)
Nov 28, 2018 - Novartis (NVS) obtains EC approval for Ziextenzo, the biosimilar of Amgen's Neulasta.
Nov 28, 2018 - Wall Street closed sharply higher on Tuesday after comments from a top U.S. economic adviser raised hopes for a solution to the ongoing trade war with China
Nov 23, 2018 - Spark Therapeutics (NASDAQ:ONCE) announces that the European Commission (EC) has granted marketing authorization for LUXTURNA (voretigene neparvovec), a one-time gene therapy for the treatmen